Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00180466 · ClinicalTrials.gov registry record
PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 697
- Enrollment target
NCT00180466 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 697 participants.
The verdict
NCT00180466 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 697 participants
- Enrollment target
Study Summary
PROSPECT is a multi-center prospective registry of Acute Coronary Syndromes (ACS) patients with single or double vessel coronary artery disease. Approximately 700 patients with ACS will be enrolled into the study at sites in the United States and European Union.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 697 participants |
| Start Date | 2004-10 |
| Est. Completion | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00180466
The ClinicalTrials.gov registry entry for NCT00180466 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 697 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00180466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00180466 about?
NCT00180466 is a clinical study titled "PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions". PROSPECT is a multi-center prospective registry of Acute Coronary Syndromes (ACS) patients with single or double vessel coronary artery disease. Approximately 700 patients with ACS will be enrolled into the study at sites in the United States and European Union.
What is the current status of trial NCT00180466?
This trial is currently completed. The enrollment target is 697 participants. The study started on 2004-10. Estimated completion is 2009-07.
Who is sponsoring clinical trial NCT00180466?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.